Markets:

Overview

News

Currencies

International

Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

6.915 -0.275 (-3.82%)

Streaming Delayed Price Updated: 2:29 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Puma Biotechnology Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 26, 2022

Via Benzinga

Why Shares of Puma Biotechnology Rose This Week ↗

December 15, 2022

The company's CEO bought $2.5 million worth of company stock.

Via The Motley Fool

Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium

December 07, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

December 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 25, 2022

Via Benzinga

Why Puma Biotechnology's Shares Jumped 20% on Monday ↗

November 21, 2022

It may have benefited from positive news about another company's drug candidate.

Via The Motley Fool

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings ↗

November 17, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 21, 2022

During Monday's session, 50 stocks hit new 52-week highs.

Via Benzinga

S&P 500 Down 1%; Crude Oil Drops Sharply ↗

November 17, 2022

U.S. stocks traded lower midway through trading, with the S&P 500 dropping around 1% on Thursday.

Via Benzinga

Short Volatility Alert: Puma Biotechnology, Inc. ↗

November 09, 2022

On Tuesday, shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) experienced volatile short activity. After the activity, the stock price went up +3.99% to $3.26. The overall sentiment for PBYI has been...

Via Benzinga

Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday ↗

November 07, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 04, 2022

Gainers

Via Benzinga

Puma Biotechnology Reports Third Quarter 2022 Financial Results

November 03, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology's Earnings Outlook ↗

November 02, 2022

Puma Biotechnology (NASDAQ:PBYI) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Puma...

Via Benzinga

Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib in EGFR Exon 18-Mutant NSCLC at the 2022 EORTC/NCI/AACR Symposium

October 27, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

October 20, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer ↗

September 21, 2022

Via Benzinga

Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor

September 20, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Presents Updated Findings from the Phase II SUMMIT Basket Trial of Neratinib for HER2-Mutant, Recurrent/Metastatic Cervical Cancer at the ESMO Congress 2022

September 11, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology to Present at the H.C. Wainwright 24th Annual Global Investment Conference

September 06, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

September 02, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

August 05, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Second Quarter 2022 Financial Results

August 04, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results

July 21, 2022

From Puma Biotechnology, Inc.

Via Business Wire

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

July 06, 2022

From Puma Biotechnology, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.